/VRCDF
VRCDF Stock - Verici Dx plc
Healthcare|Medical - Diagnostics & ResearchOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
46
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.58
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VRCDF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.55
52W High$0.12
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.34M | $1.01M | N/A | N/A | N/A |
| Gross Profit | $3.34M | $1.01M | $-628,371 | $-430,274 | $-204,916 |
| Gross Margin | 100.0% | 100.0% | N/A | N/A | N/A |
| Operating Income | $-6,106,000 | $-8,867,000 | $-11,455,000 | $-8,329,829 | $-4,509,306 |
| Net Income | $-5,874,000 | $-8,734,000 | $-11,407,000 | $-8,329,829 | $-5,047,367 |
| Net Margin | -175.9% | -862.2% | N/A | N/A | N/A |
| EPS | $-0.03 | $-0.05 | $-0.07 | $-0.06 | $-0.06 |
Company Overview
Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its in-development tests include Clarava, a pre-transplant prognosis test for the risk of early acute rejection; Tuteva, a post-transplant test that focuses on acute cellular rejection; and Protega, a liquid biopsy that aims to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Penarth, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VRCDFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2025
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q2 24
No data
Q3 24
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Jun 1, 2026 | — | — | — | — |
Q3 2025 | Jul 18, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 28, 2025 | — | $-0.02 | — | — |
Q3 2024 | Sep 24, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 30, 2024 | — | $-0.02 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.03 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.04 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.03 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.03 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.03 | — | — |
Q4 2020 | Dec 30, 2020 | — | $-0.03 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about VRCDF
What is VRCDF's current stock price?
Verici Dx plc (VRCDF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for VRCDF?
No analyst price targets are currently available for this stock.
What sector is Verici Dx plc in?
Verici Dx plc operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.
What is VRCDF's market cap?
Verici Dx plc has a market capitalization of $0.00 billion, making it a small-cap company.
Does VRCDF pay dividends?
No, Verici Dx plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorABDXF
Abingdon Health Plc
$0.07
Mkt Cap: $0.0B
ATBPF
Antibe Therapeutics Inc.
$0.22
Mkt Cap: $0.0B
AVEFF
Avecho Biotechnology Limited
$0.00
Mkt Cap: $0.0B
CNPOF
RIV Capital Inc.
$0.08
Mkt Cap: $0.0B
LVCLY
Living Cell Technologies Limited
$0.03
Mkt Cap: $0.0B
LXXGF
LexaGene Holdings Inc.
$0.08
Mkt Cap: $0.0B
MGCLF
MGC Pharmaceuticals Limited
$0.27
Mkt Cap: $0.0B
MRVFF
Nuvo Pharmaceuticals Inc.
$0.98
Mkt Cap: $0.0B
MXDHF
MDxHealth S.A.
$0.25
Mkt Cap: $0.0B
SQIDF
SQI Diagnostics Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to VRCDF for comparison